Skip to content

Myriad Genetics MYGN Change in Inventories

Change in Inventories at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
-$35.4M-321%
NeoGenomics logo
NeoGenomicsNEO
$1.27M-58.0%
Guardant Health logo
Guardant HealthGH
-$2.03M-133%
Natera, Inc. logo
Natera, Inc.NTRA
$2.28M-59.5%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$332K-63.6%
GeneDx Holdings logo
GeneDx HoldingsWGS
-$1.69M-183%

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's change in inventories?
Myriad Genetics (MYGN) reported change in inventories of -$2.7M in Q1 2026.
How has Myriad Genetics's change in inventories changed year-over-year?
Myriad Genetics's change in inventories decreased by 400.0% year-over-year, from $900K to -$2.7M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.